Search

everythinglearnresearchcommunity

for

Search:↓

Androgenetic alopecia is influenced by multiple genes and pathways, with genetic risk varying by population, and personalized treatments are being explored.

MicroRNA-22-3p hinders hair regrowth in male pattern baldness by affecting a specific protein.

Smoking increases the risk and severity of male pattern baldness.

VLDL could be an early warning sign for male pattern baldness.

Finasteride treatment in rats changed the expression of genes related to psychiatric and neurological functions, and these changes persisted after stopping the drug.

Oral Minoxidil effectively treats male pattern baldness.

Researchers created a new mouse model for studying Citrullinemia Type I and similar conditions, showing symptoms and treatment responses like those in humans.

Higher miR-34a levels and the A variant of the MIR-34A gene are linked to increased risk and severity of alopecia areata.

Female cuckoo color differences are linked to their unique genes and help avoid male harassment.

Certain genetic markers and low vitamin D3 levels are linked to male pattern baldness.

A specific RNA can help hair growth in baldness by boosting stem cell activity.

Guava leaf extract may help treat hair loss and protect cells by blocking certain genes and fighting damaging molecules.

Microneedling alone is as effective as microneedling with platelet-rich plasma for male pattern baldness.

Finasteride may cause infertility in rats by affecting epididymis and sperm function.

Inhibiting connective tissue sheath contraction may improve hair growth in male pattern baldness.

Certain gut bacteria may increase or decrease the risk of male pattern baldness.

Hair stem cells produce a protein called COL17A1 that plays a key role in their development and is linked to hair thinning and baldness.

Higher leptin and lower vitamin D levels may contribute to male pattern baldness.

Hair loss in women is genetic, diagnosed by examination and biopsy, and treated with minoxidil, finasteride, or transplantation.

Dihydrotestosterone treatment on 2D and 3D-cultured skin cells slows down hair growth by affecting certain genes and could be a potential target for hair loss treatment.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Male androgenetic alopecia involves hair follicle miniaturization due to DHT, with potential treatments using inhibitors and blockers.

Certain immune molecules and stress affect hair loss, and while genes play a role, more research is needed to fully understand and treat it.

Androgens affect hair growth and shedding, with genetic and non-genetic factors influencing baldness.

Trilostane treatment successfully restored hair growth in a dog with alopecia X.

Cholesterol sulfate buildup due to a genetic mutation disrupts the skin barrier, leading to the scaling skin seen in X-linked ichthyosis.

Technique creates 3D cell spheroids for hair-follicle regeneration.

Lipid peroxides can cause early hair loss by damaging hair follicles.

Certain genetic variations are linked to increased androgen levels in PCOS, but more research is needed to understand these connections fully.

Mutations in certain receptors can cause diseases and offer new treatment options.